AlphaCore Capital LLC quarter change: Foreign Other Stocks, Reduced
In shares no fund filing gives a ticker for, so this site has no page for them (depositary receipts and foreign shares traded over the counter), from the quarter ended 2026-03-31 to 2026-06-30, AlphaCore Capital LLC opened 0 positions, added to 0, reduced 0, sold out of 1 and left 0 unchanged. The largest increase in value was ONCOLYTICS BIOTECH INC (-$10,610); the largest decrease was ONCOLYTICS BIOTECH INC (-$10,610).
Two Form 13F-HR filings compared (SEC CIK 1713662): 2026-03-31 (filed 2026-05-15) and 2026-06-30 (filed 2026-08-06). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move; share change is the position change.
No position of this class changed this way between the two filings.
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| DV Trading LLC | United States | $4.219B | 460 |
| Ashton Thomas Private Wealth, LLC | United States | $4.225B | 1,524 |
| Bellevue Group AG | Switzerland | $4.202B | 167 |
| Nearwater Capital Markets, Ltd | United States | $4.239B | 82 |
| Wilmington Savings Fund Society, FSB | United States | $4.196B | 2,009 |
| MIZUHO SECURITIES USA LLC | United States | $4.243B | 689 |
| ADVENT INTERNATIONAL, L.P. | United States | $4.244B | 31 |
| Valeo Financial Advisors, LLC | United States | $4.185B | 794 |
| HUB Investment Partners, LLC | United States | $4.181B | 1,150 |
| SUMITOMO LIFE INSURANCE CO | Japan | $4.255B | 282 |